CClinicalTrials.gg
TerminatedNCT01214070Updated Jun 16, 2017

Functional Vision in TBI

A Phase 4 interventional study of Vision Restoration Therapy and NVT Eye Scanning Therapy in Brain Injuries and Visually Impaired Persons, sponsored by VA Office of Research and Development. Terminated at 1 site in United States. Open to participants aged 20 Years to 79 Years. Per ClinicalTrials.gov, last updated 2017-06-16.

Sponsored by VA Office of Research and Development · Phase 4, Interventional, and Treatment

Why this study was terminated
Administrative Closure
Phase
Phase 4
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
20 Years to 79 Years
Sex
All
01

Study summary

The objective of this study is to test functional vision outcome measures that reflect the loss in everyday life tasks that require vision and that are sensitive to changes after a course of vision rehabilitation in Veterans/participants with TBI.

Read the detailed description

Traumatic brain injury (TBI) can cause vision loss because of diffuse or focal neuronal injury. Vision can be compromised because of local injury to one or both optic nerves, diffuse brain injury, and/or limitation in eye movements because of dysfunction of cranial nerves. These typical injuries may compromise any of the neural pathways that subserve afferent or efferent visual function. Self-reports of vision loss include diplopia, visual field loss, light sensitivity, reading problems and contrast sensitivity (color and luminance) loss. This project will pursue the following aims: 1) Identify the relationship between functional vision loss in everyday vision tasks (reading, visual search, way finding) and the characteristics of potential visual impairment (visual acuity, contrast sensitivity, visual fields, stereoacuity, eye movement disorders) associated with TBI; and 2) Determine the ability of the vision rehabilitation interventions (both monotherapy and combination therapy) to improve functional vision outcome measures that reflect everyday visual tasks. The vision rehabilitation interventions incorporated into this study will be Vision Restoration Therapy, NVT Eye Scanning Therapy, and standard Eccentric Viewing Training. These therapies are rehabilitative interventions prescribed for Veterans in Polytrauma Rehabilitation Centers, Blind Rehabilitation Centers, and advocated for VA Medical Center TBI clinics.

02

Conditions studied

  • Brain Injuries
  • Visually Impaired Persons

Browse trials for

Keywords

  • Visual Perception
  • Vision, Ocular
  • Neuronal Plasticity
03

In context

Brain Injuries

2,113 studies on the registry are indexed under Brain Injuries; 385 are open to participants now.

This study's planned enrollment of 110 is above the median of 48 across 1,331 interventional studies indexed under Brain Injuries.

Browse Brain Injuries studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • TBI (any form)
  • Hemianopic Visual Field Loss
  • Stable fixation
  • 1.0 logMAR or better Reading Acuity
  • 20 words per minute or better reading rate

Exclusion criteria

Exclusion Criteria:

  • Visual Neglect
  • medical conditions that prevent sitting for 30 minutes or following instructions
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
110 participants (estimated)

Study arms

  • Active comparator
    Arm 1

    Group 1 - Combination Treatment

    Other: Vision Restoration Therapy · Behavioral: NVT Eye Scanning Therapy

  • Active comparator
    Arm 2

    Group 2 - Combination Treatment

    Behavioral: Eccentric Viewing Training

  • Active comparator
    Arm 3

    Group 3 - Combination Treatment

    Other: Vision Restoration Therapy · Behavioral: NVT Eye Scanning Therapy

  • Active comparator
    Arm 4

    Group 4 - Combination Treatment

    Behavioral: Eccentric Viewing Training

  • Active comparator
    Arm 5

    Group 5 - Monotherapy Treatment

    Other: Vision Restoration Therapy · Behavioral: Sham

  • Active comparator
    Arm 6

    Group 6 - Monotherapy Treatment

    Behavioral: Eccentric Viewing Training · Behavioral: Sham

  • Active comparator
    Arm 7

    Group 7 - Monotherapy Treatment

    Behavioral: NVT Eye Scanning Therapy · Behavioral: Sham

Interventions

  • OtherVision Restoration Therapy

    Therapy that enhances the neuronal plasticity of the visual system

  • BehavioralNVT Eye Scanning Therapy

    Therapy that trains eye and head scanning into the blind hemianoptic visual field

  • BehavioralEccentric Viewing Training

    Therapy that trains the person to compensate for visual field loss by learning to move the visual field loss to the position that is least likely to impact the current visual task

  • BehavioralSham

    Therapy that encourages subjects to do daily visual tasks at home while having no training or intended intervention benefit

06

What researchers measure

Primary outcomes

  1. Dynamic Visual Field

    Time frame: Baseline

Secondary outcomes

  1. Dynamic Visual Field

    Time frame: After First Therapy / Before Second Therapy (Average time is 4.5 months)

  2. Dynamic Visual Field

    Time frame: After Second Therapy (Average Time is 9 months)

  3. Reading Rate and Accuracy

    Time frame: Baseline

  4. Reading Rate

    Time frame: After First Therapy / Before Second Therapy (average time is 4.5 months)

  5. Reading Rate and Accuracy

    Time frame: After Second Therapy (average time is 9 months)

  6. Visual Search Accuracy and Timing

    Time frame: Baseline

  7. Visual Search Accuracy and Timing

    Time frame: After First Therapy / Before Second Therapy (average time is 4.5 months)

  8. Visual Search Accuracy and Timing

    Time frame: After Second Therapy (average time is 9 months)

07

Study locations

1 site
  • VA Palo Alto Health Care System
    Palo Alto, California 94304-1290, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 16, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01214070
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
Oct 4, 2010
Start date
Jun 1, 2012
Primary completion
Nov 21, 2013
Completion
Nov 21, 2013
Last update
Jun 16, 2017

Study contacts

Ron Schuchard, PhD
principal investigator · VA Palo Alto Health Care System

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jun 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion